REX (REX) Q4 2025 Earnings Call Transcript

REX delivered record fiscal 2025 results with diluted EPS of $2.50 and net income attributable to shareholders of $83.0M (vs $58.2M prior year), while ethanol sales reached a company high of 290M gallons. The company recognized approximately $28M of 45Z tax credits in 2025, has invested ~$166M to date in ethanol capacity and carbon capture (total project budget $220–230M), and expects One Earth Energy capacity to reach 200M gallons with commissioning in 2026. The carbon capture facility is built but Class VI permitting/injection timing moved to September 2026, creating near-term regulatory timing risk despite a strong balance sheet (cash ~$375.8M, zero bank debt).

Analysis

REX’s position is a classic option-on-an-asset: the firm has asymmetric upside if its low‑carbon pathway (via carbon capture + CI improvement) clears regulatory and verification milestones, because tax-credit economics convert a commodity margin business into one with durable per‑unit subsidy optionality. That optionality is time‑sensitive and lumpy — value is concentrated around discrete certification and permitting outcomes, and the market should price in both the probability and timing of certification rather than treating the credit stream as steady-state cash flow.

First‑order winners extend beyond REX: any ethanol producer that can credibly lower CI scores sooner will gain an export/ blending share advantage and capture tax credit spreads; processors that cannot will face demand softness or margin compression as lower‑CI barrels become preferred by blenders and importers. There is also a supply‑chain twist: pipeline and sequestration permitting bottlenecks create a short-term scarcity premium for permitted sequestration capacity, which favors firms with completed infrastructure and cash buffers to monetize credits quickly.

Primary risks are binary regulatory outcomes, policy windowing (finite multi‑year credit programs), and commodity price reversals that compress ethanol vs gasoline spreads. That makes a staging strategy optimal: size exposure to the regulatory binary with limited downside via option structures, then add duration exposure to the commodity/export cycle if milestones are achieved or if a sustained export premium emerges.

Key Decisions for Investors

• Buy REX (REX) equity sized 0.5%–1.0% of NAV as a staged position into the regulatory campaign; set a tactical stop-loss at 18% and a 12-month target of +35%–45% if permits/CI certification progress materializes — R/R asymmetric because upside is concentrated around getting permitted and monetizing higher credits.
• Buy a directional call spread on REX (Dec 2026): buy 20% OTM calls and sell 40% OTM calls (ratio 1:1). Max loss = premium paid; upside ~3x–5x if certification or commissioning drives a post‑event rerating before expiry. Use this to concentrate capital on the binary catalyst while capping downside.
• Event hedge for equity holders: purchase 6–9 month puts 12%–18% OTM as insurance against regulatory delay or a policy cliff; cost should be sized to limit portfolio drawdown to desired tolerance (e.g., buy protection equal to 25% of position notional).
• Short-duration catalyst trade (high risk): if implied volatility compresses ahead of the permit decision, consider buying 1–3 month calls (or call calendars) into the decision date to capture a directional pop—limit allocation to <0.25% NAV because event outcomes are binary and can move IV both ways.